Article Information
History
- January 10, 2022.
Article Versions
- Version 1 (December 29, 2021 - 08:34).
- You are viewing Version 2, the most recent version of this article.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.
Author Information
- Darui Gao1,2,3,*,
- Rong Hua1,2,3,*,
- Dina Jiesisibieke4,
- Yanjun Ma1,2,3,
- Chenglong Li1,2,3,
- Sijing Wu5,
- Qian Ma5,# and
- Wuxiang Xie1,2,3,#
- 1Peking University Clinical Research Institute, Peking University First Hospital, Beijing, China
- 2PUCRI Heart and Vascular Health Research Center at Peking University Shougang Hospital, Beijing, China
- 3Key Laboratory of Molecular Cardiovascular Sciences (Peking University), Ministry of Education, Beijing, China
- 4School of Basic Medical Sciences, Peking University, Beijing, China
- 5Department of Cardiology, Beijing Anzhen Hospital, Capital Medical University, Beijing, China
- ↵#Address for correspondence: Qian Ma, MD, Department of Cardiology, Beijing Anzhen Hospital, Capital Medical University, No. 2 Anzhen Road, Chaoyang District, 100029, Beijing, China; E-mail: fsmaqian{at}163.com. Wuxiang Xie, PhD, Peking University Clinical Research Institute, Peking University First Hospital, No. 8 Xishiku Street, Xicheng District, 100034, Beijing, China; E-mail: xiewuxiang{at}hsc.pku.edu.cn.
↵* These authors contributed equally to this work.
Posted January 10, 2022.
Effects of statin therapy on coronary plaque volume by decreasing CRP/hsCRP levels: A meta-regression of randomized controlled trials
